1 – 10 of 22
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Outlining recent updates on influenza therapeutics and vaccines : A comprehensive review
(
- Contribution to journal › Scientific review
-
Mark
Factors associated with COVID-19 vaccine uptake among south African health care workers
(
- Contribution to journal › Article
-
Mark
Advances in the design and delivery of RNA vaccines for infectious diseases
(
- Contribution to journal › Scientific review
- 2023
-
Mark
High Exposure to Perfluoroalkyl Substances and Antibody Responses to SARS-CoV-2 mRNA Vaccine-an Observational Study in Adults from Ronneby, Sweden
(
- Contribution to journal › Article
- 2022
-
Mark
A group B Streptococcus alpha-like protein subunit vaccine induces functionally active antibodies in humans targeting homotypic and heterotypic strains
(
- Contribution to journal › Article
-
Mark
The exposome and immune health in times of the covid-19 pandemic
(
- Contribution to journal › Scientific review
-
Mark
Burden of vaccine-preventable diseases, trends in vaccine coverage and current challenges in the implementation of the expanded program on immunization : A situation analysis of Cameroon
(
- Contribution to journal › Scientific review
- 2021
-
Mark
Advanced biotechnology-based therapeutics
2021) p.53-77(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
COVID-19 herd immunity in the absence of a vaccine : an irresponsible approach
(
- Contribution to journal › Article
-
Mark
Persistence of hSBA titers elicited by the meningococcal serogroup B vaccine menB-FHbp for up to 4 years after a 2- or 3-dose primary series and immunogenicity, safety, and tolerability of a booster dose through 26 months
(
- Contribution to journal › Article